coagulanttherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=*
Meta Tags
Title Coagulant Therapeutics | Developing Acute Bleeding
Description CT-001 – A Novel Factor Developing medicines to treat acute bleeding through expertise and experience in both the coagulation cascade and
Keywords N/A
Server Information
WebSite coagulanttherapeutics faviconcoagulanttherapeutics.com
Host IP 198.185.159.144
Location United States
Related Websites
Site Rank
More to Explore
coagulanttherapeutics.com Valuation
US$2,298,737
Last updated: 2023-05-18 03:46:47

coagulanttherapeutics.com has Semrush global rank of 4,604,400. coagulanttherapeutics.com has an estimated worth of US$ 2,298,737, based on its estimated Ads revenue. coagulanttherapeutics.com receives approximately 265,239 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.144. According to SiteAdvisor, coagulanttherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,298,737
Daily Ads Revenue US$2,122
Monthly Ads Revenue US$63,658
Yearly Ads Revenue US$763,888
Daily Unique Visitors 17,683
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
coagulanttherapeutics.com. 600 A coagulanttherapeutics.com. 600 IP: 198.185.159.144
coagulanttherapeutics.com. 600 A coagulanttherapeutics.com. 600 IP: 198.185.159.145
coagulanttherapeutics.com. 600 A coagulanttherapeutics.com. 600 IP: 198.49.23.144
coagulanttherapeutics.com. 600 A coagulanttherapeutics.com. 600 IP: 198.49.23.145
coagulanttherapeutics.com. 3600 NS coagulanttherapeutics.com. 3600 NS Record: ns57.domaincontrol.com.
coagulanttherapeutics.com. 3600 NS coagulanttherapeutics.com. 3600 NS Record: ns58.domaincontrol.com.
coagulanttherapeutics.com. 3600 MX coagulanttherapeutics.com. 3600 MX Record: 0 coagulanttherapeutics-com.mail.protection.outlook.com.
coagulanttherapeutics.com. 3600 TXT coagulanttherapeutics.com. 3600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
HtmlToTextCheckTime:2023-05-18 03:46:47
0 Skip to Content Acute Bleeding The Science About Our Team News Partner Contact Open Menu Close Menu Acute Bleeding The Science About Our Team News Partner Contact Open Menu Close Menu Acute Bleeding The Science Folder: About Back Our Team News Partner Contact Coagulant Therapeutics is developing medicines to treat acute bleeding , an unmet medical need that includes postpartum hemorrhage, intracranial hemorrhage, traumatic brain injury and trauma, through it’s expertise and experience in both the coagulation cascade and biologics. Acute bleeding is an unmet need with no approved treatments. The leading cause of death ages 1-46 is Acute Bleeding associated with traumatic injury* 20-40% of hemorrhage related deaths are potentially preventable with rapid hemostatic control** There are currently no approved drugs to treat acute bleeding More about acute bleeding *Centers for Disease Control and Prevention, National Center for Injury Prevention and Control **Tisherman et al., 2015. Ann
HTTP Headers
HTTP/1.1 301 Moved Permanently
Age: 22256
Date: Thu, 12 May 2022 02:10:29 GMT
Location: https://www.coagulanttherapeutics.com/
Server: Squarespace
Set-Cookie: crumb=BRx+RwtZu9xWNjRkNDM3N2U0N2ZhZmE3NjJhNWMwNjJmOWI1NzNk;Path=/
X-Contextid: 7aPsqIYT/IKo4fiDc

HTTP/2 200 
accept-ranges: bytes
age: 15834
content-type: text/html;charset=utf-8
date: Thu, 12 May 2022 03:57:31 GMT
etag: W/"90e389609c7c25c544cadd6eb0d9c9c4"
expires: Thu, 01 Jan 1970 00:00:00 GMT
server: Squarespace
set-cookie: crumb=BRwSQvZc2EN3YjVjNzcxMTRmN2M4MGExYTgzMDJhZjY1ZDc1NzI5;Path=/
strict-transport-security: max-age=43200
vary: Accept-Encoding
x-content-type-options: nosniff
x-contextid: 1xyvz2Zu/CU0sQ4Cn
content-length: 40272
coagulanttherapeutics.com Whois Information
Domain Name: COAGULANTTHERAPEUTICS.COM
Registry Domain ID: 2074736886_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-11-23T03:41:20Z
Creation Date: 2016-11-16T22:44:00Z
Registry Expiry Date: 2023-11-16T22:44:00Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS57.DOMAINCONTROL.COM
Name Server: NS58.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-05-12T08:28:09Z <<<